| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
11,475 |
10,960 |
$253K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
11,378 |
10,915 |
$251K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
721 |
653 |
$123K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
24,072 |
22,127 |
$123K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,531 |
4,050 |
$115K |
| 87040 |
|
10,154 |
7,390 |
$99K |
| 87081 |
|
22,075 |
20,392 |
$65K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,735 |
3,708 |
$55K |
| 86235 |
|
1,206 |
1,138 |
$47K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
5,052 |
4,823 |
$45K |
| 87640 |
|
1,882 |
1,805 |
$44K |
| 87088 |
|
5,105 |
4,858 |
$29K |
| 87075 |
|
4,137 |
3,488 |
$28K |
| 86780 |
|
3,079 |
2,776 |
$26K |
| 84702 |
|
5,219 |
4,102 |
$24K |
| 82784 |
|
2,393 |
2,164 |
$20K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,195 |
2,097 |
$20K |
| 87340 |
|
2,814 |
2,626 |
$18K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,339 |
2,245 |
$17K |
| 83516 |
|
3,160 |
2,816 |
$16K |
| 87496 |
|
712 |
693 |
$16K |
| 84466 |
|
2,985 |
2,852 |
$13K |
| 87205 |
|
6,746 |
5,485 |
$13K |
| 87481 |
|
1,838 |
1,777 |
$13K |
| 84153 |
|
1,715 |
1,644 |
$11K |
| 86225 |
|
1,866 |
1,578 |
$11K |
| 80074 |
|
569 |
536 |
$11K |
| 86803 |
|
1,330 |
1,289 |
$11K |
| 83883 |
|
1,081 |
910 |
$11K |
| 87070 |
|
3,157 |
2,723 |
$10K |
| 86706 |
|
1,404 |
1,335 |
$9K |
| 80202 |
|
1,357 |
740 |
$9K |
| 83520 |
|
1,321 |
413 |
$8K |
| 87505 |
|
866 |
828 |
$8K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
737 |
695 |
$7K |
| 82378 |
|
951 |
746 |
$6K |
| 87116 |
|
888 |
733 |
$6K |
| 82043 |
|
2,921 |
2,788 |
$6K |
| 82105 |
|
644 |
620 |
$5K |
| 86160 |
|
637 |
557 |
$5K |
| 86147 |
|
258 |
236 |
$5K |
| 87338 |
|
530 |
524 |
$4K |
| 86376 |
|
898 |
858 |
$4K |
| 86787 |
|
573 |
560 |
$4K |
| 87102 |
|
1,051 |
909 |
$4K |
| 86038 |
|
521 |
491 |
$4K |
| 81025 |
|
1,762 |
1,594 |
$4K |
| 86300 |
|
321 |
277 |
$3K |
| 87206 |
|
1,029 |
885 |
$3K |
| 86200 |
|
622 |
555 |
$3K |
| 83010 |
|
727 |
581 |
$3K |
| 86593 |
|
1,584 |
1,514 |
$3K |
| 86704 |
|
427 |
413 |
$3K |
| 87536 |
|
66 |
62 |
$3K |
| 87430 |
|
354 |
345 |
$3K |
| 87077 |
|
1,019 |
768 |
$3K |
| 87631 |
|
52 |
51 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
104 |
102 |
$3K |
| 86765 |
|
484 |
450 |
$2K |
| 84154 |
|
308 |
290 |
$2K |
| 87210 |
|
862 |
832 |
$2K |
| 82274 |
|
393 |
392 |
$2K |
| 86431 |
|
546 |
468 |
$2K |
| 87517 |
|
205 |
201 |
$2K |
| 87177 |
|
491 |
474 |
$2K |
| 87493 |
|
80 |
76 |
$2K |
| 86304 |
|
143 |
130 |
$2K |
| 86316 |
|
188 |
177 |
$1K |
| 86301 |
|
113 |
88 |
$1K |
| 84165 |
|
135 |
123 |
$941.29 |
| 87046 |
|
317 |
292 |
$806.28 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
68 |
63 |
$612.00 |
| 86762 |
|
129 |
122 |
$554.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
12 |
12 |
$254.42 |
| 86645 |
|
13 |
12 |
$108.27 |
| 87045 |
|
13 |
12 |
$78.90 |